Combination of simvastatin and imatinib sensitizes the CD34+ cells in K562 to cell death

Medical Oncology

Volumn 28, Issue 2, 2011, Pages 528-531

  Chen, Rui ^a   Xiao, Wei ^b   Li, Ding ^c   Mu, Shijie ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c Chinese People's Liberation Army   (China)

Author keywords

Imatinib; K562; Leukemia stem cell; Simvastatin

Indexed keywords

ACETYLCYSTEINE; IMATINIB; REACTIVE OXYGEN METABOLITE; SIMVASTATIN;

APOPTOSIS; ARTICLE; BREAST CELL; CANCER RESISTANCE; CANCER STEM CELL; CELL PROLIFERATION; CELL SUBPOPULATION; CELL SURVIVAL; CELL VIABILITY; DRUG POTENTIATION; LEUKEMIA CELL; PRIORITY JOURNAL;

ANTIGENS, CD34; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL DEATH; CELL LINE, TUMOR; CELL SEPARATION; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; FLOW CYTOMETRY; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; NEOPLASTIC STEM CELLS; PIPERAZINES; PYRIMIDINES; REACTIVE OXYGEN SPECIES; SIMVASTATIN;

EID: 79960311174     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9472-9     Document Type: Article

References (21)

1. MW Deininger JM Goldman JV Melo 2000 The molecular biology of chronic myeloid leukemia Blood 96 3343 3356 11071626 1:CAS:528:DC%2BD3cXotFKktb8%3D
2. BJ Druker F Guilhot SG O'Brien I Gathmann H Kantarjian N Gattermann MW Deininger RT Silver JM Goldman RM Stone F Cervantes A Hochhaus BL Powell JL Gabrilove P Rousselot J Reiffers JJ Cornelissen T Hughes H Agis T Fischer G Verhoef J Shepherd G Saglio A Gratwohl JL Nielsen JP Radich B Simonsson K Taylor M Baccarani C So L Letvak RA Larson 2006 Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia N Engl J Med 355 2408 2417 17151364 10.1056/NEJMoa062867 1:CAS:528:DC%2BD28Xht12ntrzM (Pubitemid 44903745)
3. H Konig M Holtz H Modi P Manley TL Holyoake SJ Forman R Bhatia 2008 Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors Leukemia 22 748 755 18273048 10.1038/sj.leu.2405086 1:CAS:528: DC%2BD1cXks12rtL8%3D (Pubitemid 351552624)
4. Z Tothova R Kollipara BJ Huntly BH Lee DH Castrillon DE Cullen EP McDowell S Lazo-Kallanian IR Williams C Sears SA Armstrong E Passegue RA DePinho DG Gilliland 2007 FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress Cell 128 325 339 17254970 10.1016/j.cell.2007.01.003 1:CAS:528:DC%2BD2sXhsVOqsr0%3D (Pubitemid 46137992)
5. K Naka T Hoshii T Muraguchi Y Tadokoro T Ooshio Y Kondo S Nakao N Motoyama A Hirao 2010 TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia Nature 463 676 80 20130650 10.1038/nature08734 1:CAS:528:DC%2BC3cXhsVygtL4%3D
6. J Liu L Cao J Chen S Song IH Lee C Quijano H Liu K Keyvanfar H Chen LY Cao BH Ahn NG Kumar II Rovira XL Xu M van Lohuizen N Motoyama CX Deng T Finkel 2009 Bmi1 regulates mitochondrial function and the DNA damage response pathway Nature 459 387 392 19404261 10.1038/nature08040 1:CAS:528:DC%2BD1MXlt1SrsbY%3D
7. A Rizo S Olthof L Han E Vellenga G de Haan JJ Schuringa 2009 Repression of BMI1 in normal and leukemic human CD34(+) cells impairs self-renewal and induces apoptosis Blood 114 1498 1505 19556423 10.1182/blood-2009-03-209734 1:CAS:528:DC%2BD1MXhtVyiur3O
8. O Hernandez-Perera D Perez-Sala J Navarro-Antolin R Sanchez-Pascuala G Hernandez C Diaz S Lamas 1998 Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells J Clin Invest 101 2711 2719 9637705 10.1172/JCI1500 1:CAS:528: DyaK1cXktVSiurw%3D (Pubitemid 28294580)
9. JF Plehn BR Davis FM Sacks JL Rouleau MA Pfeffer V Bernstein TE Cuddy LA Moye LB Piller J Rutherford LM Simpson E Braunwald 1999 Reduction of stroke incidence after myocardial infarction with pravastatin: the cholesterol and recurrent events (CARE) study. The care investigators Circulation 99 216 223 9892586 1:CAS:528:DyaK1MXhtVersbw%3D (Pubitemid 29056362)
10. PM Ridker N Rifai MA Pfeffer FM Sacks LA Moye S Goldman GC Flaker E Braunwald 1998 Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events (CARE) investigators Circulation 98 839 844 9738637 1:CAS:528:DyaK1cXlvFyhur0%3D (Pubitemid 28397432)
11. FM Sacks MA Pfeffer LA Moye JL Rouleau JD Rutherford TG Cole L Brown JW Warnica JM Arnold CC Wun BR Davis E Braunwald 1996 The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators N Engl J Med 335 1001 1009 8801446 10.1056/NEJM199610033351401 1:CAS:528:DyaK28XmsFWls7c%3D (Pubitemid 26338729)
12. JR Downs M Clearfield S Weis E Whitney DR Shapiro PA Beere A Langendorfer EA Stein W Kruyer AM Gotto Jr 1998 Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air force/texas coronary atherosclerosis prevention study Jama 279 1615 1622 9613910 10.1001/jama.279.20.1615 1:STN:280:DyaK1c3ntl2qsw%3D%3D (Pubitemid 28248586)
13. SJ Cho JS Kim JM Kim JY Lee HC Jung IS Song 2008 Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice Int J Cancer 123 951 957 18521906 10.1002/ijc.23593 1:CAS:528:DC%2BD1cXovFWmu7g%3D (Pubitemid 352032426)
14. N Ghosh-Choudhury CC Mandal N Ghosh-Choudhury G Ghosh Choudhury 2010 Simvastatin induces derepression of PTEN expression via NFkappaB to inhibit breast cancer cell growth Cell Signal 22 5 749 58 20060890 10.1016/j.cellsig. 2009.12.010 1:CAS:528:DC%2BC3cXit1WqtLg%3D
15. ER Garwood AS Kumar FL Baehner DH Moore A Au N Hylton CI Flowers J Garber BA Lesnikoski ES Hwang O Olopade ER Port M Campbell LJ Esserman 2010 Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer Breast Cancer Res Treat 119 1 137 44 19728082 10.1007/s10549-009-0507-x 1:CAS:528:DC%2BD1MXhsFaqtrrO
16. MJ Campbell LJ Esserman Y Zhou M Shoemaker M Lobo E Borman F Baehner AS Kumar K Adduci C Marx EF Petricoin LA Liotta M Winters S Benz CC Benz 2006 Breast cancer growth prevention by statins Cancer Res 66 8707 8714 16951186 10.1158/0008-5472.CAN-05-4061 1:CAS:528:DC%2BD28XovF2hsrY%3D (Pubitemid 44449187)
17. H Seeger D Wallwiener AO Mueck 2003 Statins can inhibit proliferation of human breast cancer cells in vitro Exp Clin Endocrinol Diabetes 111 47 48 12605351 10.1055/s-2003-37501 1:CAS:528:DC%2BD3sXitlKrsrY%3D (Pubitemid 36336817)
18. S Kotamraju CL Williams B Kalyanaraman 2007 Statin-induced breast cancer cell death: role of inducible nitric oxide and arginase-dependent pathways Cancer Res 67 7386 7394 17671209 10.1158/0008-5472.CAN-07-0993 1:CAS:528:DC%2BD2sXosVemtLw%3D (Pubitemid 47206569)
19. YC Yang DW Xiao H Liu LM Chuan YL Zeng DA Zhou W Liu GQ Xu WF Huang 2009 Mechanism of simvastatin-induced K562 cell apoptosis Pharmacology 84 191 195 19729986 10.1159/000235907 1:CAS:528:DC%2BD1MXht1KrtLbN
20. Marques DS, Sandrini JZ, Boyle RT, Marins LF, Trindade GS. Relationships between multidrug resistance (MDR) and stem cell markers in human chronic myeloid leukemia cell lines. Leuk Res. 2009.
21. ML Heaney JR Gardner N Karasavvas DW Golde DA Scheinberg EA Smith OA O'Connor 2008 Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs Cancer Res 68 8031 8038 18829561 10.1158/0008-5472.CAN-08-1490 1:CAS:528:DC%2BD1cXhtF2msLrL